Author:
Simon James A.,Clayton Anita H.,Kingsberg Sheryl A.,Parish Sharon J.,Kim Noel N.,Millheiser Leah
Funder
AbbVie Inc.
Allergan plc
Bayer HealthCare
New England Research Institutes, Inc.
AMAG Pharmaceuticals, Inc.
Amgen Inc.
US
Mitsubishi Tanabe Pharma
Sanofi
Shionogi
Janssen Pharmaceuticals, Inc.
Sage Therapeutics
Acadia
Lundbeck
Random House
Sprout Pharmaceuticals, Inc.
Subject
Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health
Reference18 articles.
1. Evaluation and management of hypoactive sexual desire disorder;Clayton;Sex Med,2018
2. Addyi (flibanserin) tablets, for oral use [prescribing information in US],2018
3. Pharmacology of flibanserin;Borsini;CNS Drug Rev,2002
4. Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain;Marazziti;Int J Neuropsychopharmacol,2002
5. Multifunctional pharmacology of flibanserin: Possible mechanism of therapeutic action in hypoactive sexual desire disorder;Stahl;J Sex Med,2011
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献